Comparative Study of Perioperative Cardiac Injury in Patients With Functional Adrenal Tumors
NCT ID: NCT07182175
Last Updated: 2025-09-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ENROLLING_BY_INVITATION
150 participants
OBSERVATIONAL
2024-09-19
2026-05-29
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The main questions it aims to answer are:
* What heart and blood pressure changes do patients with different types of adrenal tumors have before surgery?
* What factors affect how the heart and blood pressure recover after surgery?
* Do the heart and blood pressure conditions before surgery influence recovery and the risk of heart or brain problems after surgery?
Patients will have heart ultrasound checks and health monitoring before and after surgery. The results will help doctors choose the right medicines before surgery, better understand possible risks during the operation, and make safer treatment plans for patients with functional adrenal tumors.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Prospective Cohort Study for Patients With Adrenal Diseases
NCT03474237
Cardiovascular Complications After Adrenalectomy for Pheochromocytoma and Non-secreting Tumors
NCT07200245
Cardiac and Vascular Changes in Pheochromocytoma and Paraganglioma
NCT05082311
Calcitonin Level and New-onset of Post-Operative Atrial Fibrillation
NCT04993456
Study of the Relationship Between Serum Adiponectin and Clinical Prognosis in Patients Undergoing Cardiac Surgery
NCT01393535
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
primary aldosteronism
No interventions assigned to this group
Cushing s Syndrome
No interventions assigned to this group
Pheochromocytoma/Paraganglioma (PPGL)
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Written informed consent obtained.
Exclusion Criteria
* Patients with communication disorders or severe physical impairments such as aphasia, or visual/hearing disabilities;
* Patients with severe mental illness who cannot cooperate with the study;
* Pregnant women or patients otherwise deemed unsuitable for participation by the investigators.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Peking University First Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Peking University First Hospital
Beijing, , China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2024yan411-002
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.